VANCOUVER, British Columbia, Nov. 8, 2016 /PRNewswire/ -- Vanrx Pharmasystems, a manufacturer of advanced sterile fillingsolutions for the pharmaceutical industry, will launch its SA25 Aseptic Filling Workcell into the Indian market at P-MEC India 2016.
Vanrx will be exhibiting in Hall 7, Stand S13, which takes place from 21-23 November 2016
The SA25 Aseptic Filling Workcell is the world's first gloveless robotic isolator for fill-finish of injectable (parenteral) drug products. The Workcell uses robotics to perform all material handling, filling and container closing activities. It was designed by pharmaceutical veterans who wanted to solve long-standing aseptic processing problems in conventonal fill-finish systems. Their goal was to make the production of complex drug products easier and improve patient safety.
"Companies that take advantage of the technological advancements provided by the SA25 Workcell will bring their drug products to market faster and beat their competition, achieving superior market share and profitability. Vanrx has its first major customer in India and hopes to meet more companies who want to build world-class manufacturing operations at P-MEC India," said Chris Procyshyn, CEO and co-founder of Vanrx Pharmasystems.
A major generic pharmaceutical company recently installed a Vanrx Workcell at its Indian production facilities. The Workcell is an excellent fit for the Indian market, with its emphasis on generics, biosimilars and contract manufacturing. Its flexibility to fill vials, syringes or cartridges enables the production of a wide range of drug products on a single machine.
Key benefits of the SA25 Workcell include:
Interested companies can contact Vanrx to arrange a meeting at P-MEC India or from 24 November to 2 December 2016, following the exhibition.
About Vanrx Pharmasystems
Vanrx Pharmasystems makes the most technologically advanced sterile filling solutions for the pharmaceutical industry. Vanrx fill-finish machines use isolated robotics and machine vision to automate the packaging of injectable drugs into nested vials, syringes, or cartridges. The company was founded by pharmaceutical industry veterans to create the systems needed to make the next generation of innovative therapies. For more information, visit www.vanrx.com.
To schedule media interviews or request a meeting, please contact:
Eric PetzSenior Marketing ManagerVanrx PharmasystemsPhone: +1.604.453.8660 ext. 773
GRAPHIC: SA25 Workcell picture
Subscribe to our Free Newsletters!
Fasciotomy is a surgical procedure where the fascia is incised to relieve the compartmental ...
Angioedema is a condition that causes leakage of blood vessels resulting in the swelling of deeper ...
Acute coronary syndrome (ACS) is a sudden, acute life-threatening condition caused by a dramatic ...View All